Related references
Note: Only part of the references are listed.Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions
Jason H. Karnes et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement
Jennifer L. Goldman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
EASL Clinical Practice Guidelines: Drug-induced liver injury
Raul J. Andrade et al.
JOURNAL OF HEPATOLOGY (2019)
Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children
Xiuhui D. Han et al.
PEDIATRIC DERMATOLOGY (2019)
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions
Paola Nicoletti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Variation of clinical manifestations according to culprit drugs in DRESS syndrome
Da Woon Sim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019
Tetsuo Shiohara et al.
ALLERGOLOGY INTERNATIONAL (2019)
Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry
Hea Lin Oh et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Imatinib
F. Zgolli et al.
CURRENT DRUG SAFETY (2019)
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
Elizabeth J. Phillips et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals
Wendy C. Fang et al.
INTERNAL MEDICINE JOURNAL (2018)
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
I. Medina-Caliz et al.
JOURNAL OF HEPATOLOGY (2018)
Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
Kalaiyarasi Kaliyaperumal et al.
JOURNAL OF HEPATOLOGY (2018)
Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature
Abhishek De et al.
INDIAN JOURNAL OF DERMATOLOGY (2018)
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Marianne Lerch et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma
Phatcharawat Chirasuthat et al.
CASE REPORTS IN DERMATOLOGY (2018)
Drug-Induced Liver and Skin Reactions: In Need of a Consensus Definition
Inmaculada Medina-Caliz et al.
HEPATOLOGY (2017)
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Gerd A. Kullak-Ublick et al.
GUT (2017)
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions
Patricia T. Illing et al.
IMMUNOGENETICS (2017)
Prediction of drug-induced liver injury using keratinocytes
Rika Hirashima et al.
JOURNAL OF APPLIED TOXICOLOGY (2017)
Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Shih-Chi Su et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome
Sayeef Mirza et al.
MELANOMA RESEARCH (2017)
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population
Therdpong Tempark et al.
PHARMACOGENETICS AND GENOMICS (2017)
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population
Elena Ramirez et al.
PHARMACOLOGICAL RESEARCH (2017)
Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors
Philippe Ichai et al.
TRANSPLANTATION (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Cutaneous adverse drug reactions: Kids are not just little people
Reid Waldman et al.
CLINICS IN DERMATOLOGY (2017)
The HLA-A*31:01 allele: influence on carbamazepine treatment
Vincent Lai Ming Yip et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
Chun-Fang Xu et al.
CLINICAL CANCER RESEARCH (2016)
Drug-Induced Liver Injury Associated With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Patient Characteristics, Causes, and Outcome in 36 Cases
Harshad Devarbhavi et al.
HEPATOLOGY (2016)
Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications
Lily Dara et al.
LIVER INTERNATIONAL (2016)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
HLA and Delayed Drug-Induced Hypersensitivity
Bernardo Sousa-Pinto et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand
Akarin Hiransuthikul et al.
ALLERGOLOGY INTERNATIONAL (2016)
HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population
Virginia Leiro-Fernandez et al.
FRONTIERS IN MEDICINE (2016)
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Naga Chalasani et al.
GASTROENTEROLOGY (2015)
Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response
Katie D. White et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Drug-induced liver injury: Interactions between drug properties and host factors
Minjun Chen et al.
JOURNAL OF HEPATOLOGY (2015)
Liver injury in patients with DRESS: A clinical study of 72 cases
I-Chun Lin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases
F. Skowron et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo et al.
JAMA DERMATOLOGY (2015)
Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review
V. L. M. Yip et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2015)
Human leukocyte antigen genetic risk factors of drug-induced liver toxicology
Jane I. Grove et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions
Amy M. Sharma et al.
DRUG METABOLISM REVIEWS (2014)
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Mercedes Robles-Diaz et al.
GASTROENTEROLOGY (2014)
Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations
David E. Kleiner et al.
HEPATOLOGY (2014)
Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study
Peiqi Su et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population
Fanping Yang et al.
PHARMACOGENOMICS (2014)
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E. Genin et al.
PHARMACOGENOMICS JOURNAL (2014)
Prolonged Evolution of Drug Reaction With Eosinophilia and Systemic Symptoms: Clinical, Virologic, and Biological Features
Florence Tetart et al.
JAMA DERMATOLOGY (2014)
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
M. Goncalo et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases
S. Walsh et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
S. H. Kardaun et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Drug reaction with eosinophilia and systemic symptoms: A drug-induced hypersensitivity syndrome with variable clinical features
Yi-Chun Chen et al.
DERMATOLOGICA SINICA (2013)
HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
Ying-Kit Cheung et al.
EPILEPSIA (2013)
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
Einar S. Bjornsson et al.
GASTROENTEROLOGY (2013)
Human Leukocyte Antigen (HLA)-B☆57:01-Restricted Activation of Drug-Specific T Cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury
Manal M. Monshi et al.
HEPATOLOGY (2013)
Characteristics of liver injury in drug-induced systemic hypersensitivity reactions
Taehoon Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Predictive Genetic Testing for Drug-Induced Liver Injury: Considerations of Clinical Utility
A. Alfirevic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Patricia T. Illing et al.
NATURE (2012)
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
Jing Yuan et al.
AIDS (2011)
Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
M. Pirmohamed et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
G. P. Aithal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim et al.
EPILEPSY RESEARCH (2011)
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
M. Isabel Lucena et al.
GASTROENTEROLOGY (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Causality assessment methods in drug induced liver injury: Strengths and weaknesses
Miren Garcia-Cortes et al.
JOURNAL OF HEPATOLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality
Harshad Devarbhavi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Drug Reaction With Eosinophilia and Systemic Symptoms A Retrospective Study of 60 Cases
Yi-Chun Chen et al.
ARCHIVES OF DERMATOLOGY (2010)
ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis
B. Sassolas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Retrospective analysis of drug-induced hypersensitivity syndrome: A study of 27 patients
Chia-Chun Ang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Jonathan B. Singer et al.
NATURE GENETICS (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response
Damien Picard et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms A Cause of Unpredictable Multiorgan Failure
Majed Eshki et al.
ARCHIVES OF DERMATOLOGY (2009)
Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex
M. Isabel Lucena et al.
HEPATOLOGY (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis
Natacha Levi et al.
PEDIATRICS (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz
Zulma G. Vitezica et al.
AIDS (2008)
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
Bruce R. Schackman et al.
AIDS (2008)
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury
M. Garcia-Cortes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
Ketevan Pachkoria et al.
JOURNAL OF HEPATOLOGY (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome
M. Tohyama et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Generation and characterization of antigen-specific CD4(+), CD8(+), and CD4(+)CD8(+) T-cell clones from patients with carbamazopine hypersensitivity
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry
Raul J. Andrade et al.
HEPATOLOGY (2006)
Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
M. Seishima et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease
Y. Kano et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Hypersensitivity to aromatic anticonvulsants: In vivo and in vitro cross-reactivity studies
Antonino Romano et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations
AR Hughes et al.
PHARMACOGENOMICS (2004)
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
A Nassif et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Delayed drug hypersensitivity reactions
WJ Pichler
ANNALS OF INTERNAL MEDICINE (2003)
Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
DJ Naisbitt et al.
MOLECULAR PHARMACOLOGY (2003)
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment
SK Sharma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
SCORTEN: A severity-of-illness score for toxic epidermal necrolysis
S Bastuji-Garin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
